G6PC1 and Hyperglycemia: PPAR activation is known to increase the phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) expression, causing hyperglycemia and insulin resistance [99]; therefore, reduced expression of this receptor protein could confer a mechanism of protection against insulin resistance, reducing the risk of diabetes and its complications [100].